Scott G. Davis - 14 Mar 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
CEO
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
14 Mar 2025
Transactions value $
$0
Form type
4
Filing time
18 Mar 2025, 18:06:18 UTC
Previous filing
18 Aug 2023
Next filing
07 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award +5,590 5,590 14 Mar 2025 By 401(k) F1
holding EKSO Common Stock 331,372 14 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were acquired in connection with the Issuer's 401(k) contribution matching program.